MEDIRELIEF- lidocaine patch 
FARLA MEDICAL HEALTHCARE LTD

----------

MediRelief Lidocaine 4% Patch

Drug Facts

Active Ingredients & Purpose

Active ingredients (in each patch) Purpose

Lidocaine 4%..............................................................................................Topical analgesic

Uses

For the temporary relief of pain.

Warnings

FOR EXTERNAL USE ONLY. Avoid contact with the eyes.

Do not use

  • in large quantities, particularly over raw surfaces or blistered areas
  • on sensitive skin
  • if allergic to any ingredients in this product

Stop use and ask a doctor if

  • condition worsens
  • redness is present
  • symptoms persist for more than 7 days or clear up and occur again within a few days

If pregnant of breast-feeding

ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

- clean dry affected area

- remove film from patch and apply to skin (see illustration)

Other Information

TAMPER EVIDENT: Do not use if pouch containing the patch is torn or broken.

Inactive Ingredients

dihydroxyaluminum aminoacetate, glycerin, kaolin, methylparaben, polyacrylic acid, polysorbate 80, povidones, propylene glycol, propylparaben, sodium polyacrylate, tartaric acid, titanium dioxide, water

Principal Display Panel

NDC: 73486-102-25
Count: (3.9”x5.5”) 5 Patches Box

MEDIRELIEF 
lidocaine patch
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73486-102
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE4 g
Inactive Ingredients
Ingredient NameStrength
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
DIHYDROXYALUMINUM AMINOACETATE ANHYDROUS (UNII: 1K713C615K)  
POVIDONE (UNII: FZ989GH94E)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
KAOLIN (UNII: 24H4NWX5CO)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
POLYACRYLIC ACID (250000 MW) (UNII: 9G2MAD7J6W)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
TARTARIC ACID (UNII: W4888I119H)  
GLYCERIN (UNII: PDC6A3C0OX)  
SODIUM POLYACRYLATE (8000 MW) (UNII: 285CYO341L)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:73486-102-255 in 1 CARTON05/26/2020
11 in 1 POUCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01705/26/2020
Labeler - FARLA MEDICAL HEALTHCARE LTD (230061759)

Revised: 2/2024
Document Id: 121939d2-7ad8-586d-e063-6294a90acf91
Set id: a698cdbc-6e34-164d-e053-2a95a90ab4d2
Version: 5
Effective Time: 20240223
 
FARLA MEDICAL HEALTHCARE LTD